Tony W. Ho

16.1k total citations · 1 hit paper
101 papers, 8.5k citations indexed

About

Tony W. Ho is a scholar working on Neurology, Psychiatry and Mental health and Pathology and Forensic Medicine. According to data from OpenAlex, Tony W. Ho has authored 101 papers receiving a total of 8.5k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Neurology, 30 papers in Psychiatry and Mental health and 24 papers in Pathology and Forensic Medicine. Recurrent topics in Tony W. Ho's work include Migraine and Headache Studies (30 papers), Trigeminal Neuralgia and Treatments (24 papers) and Peripheral Neuropathies and Disorders (21 papers). Tony W. Ho is often cited by papers focused on Migraine and Headache Studies (30 papers), Trigeminal Neuralgia and Treatments (24 papers) and Peripheral Neuropathies and Disorders (21 papers). Tony W. Ho collaborates with scholars based in United States, United Kingdom and China. Tony W. Ho's co-authors include John W. Griffin, Guy M. McKhann, Arthur K. Asbury, David R. Cornblath, Irving Nachamkin, Lars Edvinsson, Peter J. Goadsby, Ban Mishu Allos, Xiaoyin Fan and Christopher Lines and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nature Communications.

In The Last Decade

Tony W. Ho

101 papers receiving 8.3k citations

Hit Papers

Guillain-Barré syndrome in northern China Relationship to... 1995 2026 2005 2015 1995 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tony W. Ho United States 47 3.7k 3.5k 2.4k 1.8k 1.3k 101 8.5k
Klaus V. Toyka Germany 50 2.8k 0.7× 2.0k 0.6× 541 0.2× 2.1k 1.2× 921 0.7× 144 8.7k
Hayrettin Tumani Germany 50 2.9k 0.8× 901 0.3× 736 0.3× 2.4k 1.3× 1.5k 1.1× 226 8.0k
Michael P. Lunn United Kingdom 39 3.8k 1.0× 2.0k 0.6× 518 0.2× 450 0.3× 987 0.8× 179 6.5k
Klaus V. Toyka Germany 66 5.2k 1.4× 4.4k 1.2× 340 0.1× 1.4k 0.8× 2.2k 1.7× 202 12.7k
Jie Zhu Sweden 43 2.0k 0.5× 1.3k 0.4× 319 0.1× 721 0.4× 1.3k 1.0× 223 7.2k
Peter Blumbergs Australia 48 3.7k 1.0× 1.5k 0.4× 374 0.2× 744 0.4× 1.2k 0.9× 231 8.8k
Cristoforo Comi Italy 42 2.3k 0.6× 679 0.2× 461 0.2× 1.9k 1.1× 604 0.5× 205 6.0k
Christopher J. Klein United States 48 3.9k 1.1× 1.5k 0.4× 286 0.1× 340 0.2× 864 0.7× 223 7.3k
Dikran S. Horoupian United States 38 2.3k 0.6× 1.0k 0.3× 696 0.3× 305 0.2× 1.8k 1.4× 137 5.9k
Frank Leypoldt Germany 34 4.6k 1.2× 970 0.3× 412 0.2× 516 0.3× 361 0.3× 111 7.0k

Countries citing papers authored by Tony W. Ho

Since Specialization
Citations

This map shows the geographic impact of Tony W. Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tony W. Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tony W. Ho more than expected).

Fields of papers citing papers by Tony W. Ho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tony W. Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tony W. Ho. The network helps show where Tony W. Ho may publish in the future.

Co-authorship network of co-authors of Tony W. Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Tony W. Ho. A scholar is included among the top collaborators of Tony W. Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tony W. Ho. Tony W. Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Claiborne, Daniel T., Deborah Cromer, Youdiil Ophinni, et al.. (2025). High frequency CCR5 editing in human hematopoietic stem progenitor cells protects xenograft mice from HIV infection. Nature Communications. 16(1). 446–446. 3 indexed citations
2.
Chaudhari, Hemangi G., Jon Penterman, Holly Whitton, et al.. (2020). Evaluation of Homology-Independent CRISPR-Cas9 Off-Target Assessment Methods. The CRISPR Journal. 3(6). 440–453. 25 indexed citations
3.
Sagert, Jason, et al.. (2019). Abstract 1428: Allogeneic CRISPR/Cas9 gene-edited CAR-T cells targeting CD33 show potent preclinical activity against AML cells. Cancer Research. 79(13_Supplement). 1428–1428. 5 indexed citations
4.
Hodgson, Darren, Brian Dougherty, Zhongwu Lai, et al.. (2018). Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genes. British Journal of Cancer. 119(11). 1401–1409. 167 indexed citations
6.
Su, Tung‐Ping, et al.. (2016). Pharmacokinetics of a Novel Zolpidem Nasal Spray for Rapid Management of Insomnia: First Trial in Humans. Journal of Clinical Sleep Medicine. 12(11). 1453–1459. 5 indexed citations
7.
Stocchi, Fabrizio, Olivier Rascol, Robert A. Hauser, et al.. (2014). Phase-3 Clinical Trial of the Adenosine 2a Antagonist Preladenant, Given as Monotherapy, in Patients with Parkinson’s Disease (S7.004). Neurology. 82(10_supplement). 4 indexed citations
8.
Hauser, Robert A., Fabrizio Stocchi, Olivier Rascol, et al.. (2014). Phase-3 Clinical Trials of Adjunctive Therapy with Preladenant, an Adenosine 2a Antagonist, in Patients with Parkinson’s Disease (P7.087). Neurology. 82(10_supplement). 9 indexed citations
9.
Ho, Tony W., Eric Pearlman, Donald W. Lewis, et al.. (2012). Efficacy and tolerability of rizatriptan in pediatric migraineurs: Results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design. Cephalalgia. 32(10). 750–765. 54 indexed citations
10.
Hewitt, David, Sheena K. Aurora, David W. Dodick, et al.. (2011). Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine. Cephalalgia. 31(6). 712–722. 225 indexed citations
11.
Hewitt, David, Tony W. Ho, Bradley S. Galer, et al.. (2010). Impact of responder definition on the enriched enrollment randomized withdrawal trial design for establishing proof of concept in neuropathic pain. Pain. 152(3). 514–521. 38 indexed citations
12.
Hargreaves, Richard, et al.. (2009). Ten Years of Rizatriptan: From Development to Clinical Science and Future Directions. Headache The Journal of Head and Face Pain. 49(s1). S3–20. 14 indexed citations
13.
Diemunsch, Pierre, Christian C. Apfel, Tong J. Gan, et al.. (2007). Preventing postoperative nausea and vomiting: post hoc analysis of pooled data from two randomized active-controlled trials of aprepitant. Current Medical Research and Opinion. 23(10). 2559–2565. 39 indexed citations
15.
Nachamkin, Irving, Jørgen Engberg, Michaela Gutacker, et al.. (2001). Molecular Population Genetic Analysis ofCampylobacter jejuniHS:19 Associated with Guillain‐Barré Syndrome and Gastroenteritis. The Journal of Infectious Diseases. 184(2). 221–226. 46 indexed citations
16.
Jinnah, H. A., Jehuda P. Sepkuty, Tony W. Ho, et al.. (2000). Calcium channel agonists and dystonia in the mouse. Movement Disorders. 15(3). 542–551. 59 indexed citations
17.
Ho, Tony W., Lynn A. Bristol, Yun Li, et al.. (2000). TGFβ Trophic Factors Differentially Modulate Motor Axon Outgrowth and Protection from Excitotoxicity. Experimental Neurology. 161(2). 664–675. 64 indexed citations
18.
Ho, Tony W. & John H. Griffin. (1999). Guillain - Barré syndrome. Current Opinion in Neurology. 12(4). 389–394. 26 indexed citations
19.
Hafer‐Macko, Charlene E., Kazim A. Sheikh, Tony W. Ho, et al.. (1996). Immune attack on the schwann cell surface in acute inflammatory demyelinating polyneuropathy. Annals of Neurology. 39(5). 625–635. 314 indexed citations
20.
Krown, Kevin A., et al.. (1992). Prolactin isoform 2 as an autocrine growth factor for GH3 cells.. Endocrinology. 131(2). 595–602. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026